SearchCME LoginCE Login Show Cart
NACE: National Association For Continuing Education 866-266-6223 9a am to 5 pm EST Mon-Fri
CME Course Description
   
Login to view
Course Activities.

CME Live Virtual Conferences

Go Back




Title
: Emerging Challenges in Primary Care 2018 Nashville, TN
Activity/Course #:
: 09.15.18PC

Cost:
: Free
Release/Start Date:
: Sep 15 2018
Expiration Date:
: Sep 15 2018
Topics:
: Primary Care Medicine
Target Audience:
: Primary Care Providers
Format:
: Live EC Primary Care
Estimated Time To Complete CME Activity:
: 7.0 hours
Credit(s):
: 7.0 AMA PRA Category I Credit(s)
7.0 AANP Contact hour(s) which includes 3.25 pharmacology hour(s)
Hardware/Software Requirements:
Saturday, September 15, 2018
Nashville Marriott at Vanderbilt University
2555 West End Avenue
Nashville, TN 37203
(615) 321-1300

Click Here to View/Print the Slides for this Conference

Registration Fee
There is no registration fee for this activity.

Special Accommodations
NACE fully complies with the legal requirements of the Americans with Disabilities Act. Any activity registrant who feels s/he may need accommodations based on the impact of a disability should contact NACE to discuss your specific need.

Event Parking
A discounted self parking rate of $10.00 is available at the hotel.

Program Summary
Primary care providers face complex challenges everyday in their busy practices. With rapid changes in medicine, staying informed about new developments can be equally challenging. Our goal in this CME activity is to help you hone your skills in the diagnosis and management of patients with varied conditions you are likely encountering in your practice.

We have recruited a faculty of well-known thought leaders and experienced teachers who, as clinicians themselves, understand the challenges you face every day as a primary care provider. Our faculty will be at your disposal to provide evidence-based science, current treatment guidelines, discuss challenging cases, and provide answers for you that can ultimately lead to better health care for your patients. The presentations will include several interactive cases and discussion sessions to keep you actively learning.

Please join us and become an active participant in this one-day learning community of your peers.

 

Learning Objectives


At the conclusion of this program, participants should be able to:

1. Identify the barriers between clinicians and patients to discussing and initiating earlier insulin therapy for diabetes management; Discuss currently available basal and ultrabasal insulins and their pharmacokinetic/ pharmacodynamic profiles Recognize the prevalence and clinical impact of hypoglycemia in special populations at risk; Describe how best to initiate, utilize and intensify insulin therapy in patients with diabetes while incorporating treatment guidelines and unique patient needs; Integrate strategies to improve the patient experience with, and adherence to, insulin therapy.


2. Recognize the importance of early identification of patients with potential idiopathic pulmonary fibrosis (IPF); Utilize appropriate strategies to diagnose a patient with IPF while excluding other potential mimickers; Discuss the available therapeutic options for patients with IPF; Recognize the role of the primary care clinician in managing the multi-morbidities associated with IPF.


3. Describe the findings from recent trials of PCSK9i hypercholesterolemia treatments on cardiovascular outcomes; Discuss current guidelines and recommendations on the management of hyperlipidemia in high risk patients; Incorporate current data into secondary prevention treatment strategies for patients with the highest cardiovascular risk; Recognize barriers to access for PCSK9 monoclonal antibody therapy and discuss novel strategies to overcome them.


4. Recognize the role of laboratory testing and imaging in the evaluation and management of HF; Reliably assess symptom burden in patients with HF; Implement ACC/AHA/HFSA guideline directed medical therapy in the management of chronic heart failure; Recognize strategies to reduce hospitalization and readmission for HF.


5. Describe the role of persistent oncogenic HPV in the development of pre-cancer and cancer of the cervix; List the current Advisory Committee on Immunization Practice (ACIP) recommendations for appropriate use of 2 or 3 doses of 9vHPV Vaccine; Describe the use of HPV testing as co-testing along with the Pap in cervical cancer screening in women 30 and older; Describe the use of HPV primary screening in women 25 and older.

 

6. List two common menopausal symptoms women experience; List one difference in oral versus transdermal estrogen therapy from the KEEPS trial; Discuss the current risks and benefits of hormone therapy for women in the early post menopause; Discuss treatment options for vasomotor symptoms including oral and transdermal estrogen.

 

Agenda*

 7:30-8:00    
Continental Breakfast and Registration 
 8:00-8:10 Welcome Remarks
Gregg Sherman, MD
 8:10-9:40 Getting Comfortable with Insulin: New Approaches to Getting Patients Safely to Target
Rodolfo J. Galindo, MD
 9:40-10:50 Navigating the Maze of Interstitial Lung Disease: Improving Outcomes through Early
Diagnosis
David J. Lederer, MD, MS
 10:50-11:10 Break
 11:10-12:20 Managing Lipids and Cardiovascular Risk: Using the Data to Optimize Care
David Montgomery, MD, PhD, FACC
12:20-1:30
 Lunch
 1:30-2:40 Heart Failure: Optimizing Medical Therapy and Patient Communication
David Montgomery, MD, PhD, FACC
 2:40-3:50 An Update on HPV and Cervical Cancer Prevention
Nancy R. Berman, MSN, ANP-BC, NCMP, FAANP
 3:50-4:00 Break
 4:00-5:10 Managing Menopause: Update on The Role and Rationale of Hormonal Therapy
Nancy R. Berman, MSN, ANP-BC, NCMP, FAANP
5:10-5:15
 Program Summary and Closing Remarks
Gregg Sherman, MD

* Agenda subject to change

 

Faculty

Nancy R. Berman, MSN, ANP-BC, NCMP, FAANP
Adult Nurse Practitioner
Certified Menopause Practitioner
Millennium Affiliated Physicians
Division of Michigan Healthcare Professionals
Farmington Hills, MI

Rodolfo J. Galindo, MD
Assistant Professor of Medicine
Emory University School of Medicine
Principal Investigator, Center for Diabetes and Metabolism Research
Division of Endocrinology, Diabetes and Metabolism
Emory University Hospital Midtown
Medical Chair, Hospital Diabetes Taskforce
Emory Healthcare System
Atlanta, GA

David J. Lederer, MD, MS
Associate Professor of Medicine & Epidemiology
Co-Director, Interstitial Lung Disease Program
Columbia University Medical Center
New York, NY

David Montgomery, MD, PhD, FACC
Preventive Cardiologist
Piedmont Heart Institute
Atlanta, GA

Planning Committee

Gregg Sherman, MD
Chief Medical Officer/Course Director
National Association for Continuing Education
Plantation, FL


Sheila Lucas, CWEP
Activity Director
National Association for Continuing Education

Plantation, FL

Sandy Bihlmeyer, M.Ed.
National Association for Continuing Education

Plantation, FL

Michelle Frisch, MPH, CHCP
National Association for Continuing Education

Plantation, FL

Cassandra A. McCullough, MBA

Chief Executive Officer
Association of Black Cardiologists
New York, NY

Harvey C. Parker, Ph.D., CHCP
National Association for Continuing Education

Plantation, FL

Sponsored and Certified By
National Association for Continuing Education & Association of Black Cardiologists, Inc.
Accreditation Designation Statement
The Association of Black Cardiologists, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Association of Black Cardiologists, Inc. designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The National Association for Continuing Education designates this live activity for a maximum of 6.0 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The National Association for Continuing Education is approved as a provider of nurse practitioner continuing education by the American Association of Nurse Practitioners. AANP Provider Number 121222. This program has been approved for 7.0 contact hours of continuing education (which includes 3.25 pharmacology hours).
Faculty Disclosure Policy
Policy on Faculty and Provider Disclosure: It is the policy of the accredited providers to ensure fair balance, independence, objectivity and scientific rigor in all activities. All faculty participating in CME activities sponsored by the accredited providers are required to present evidence-based data, identify and reference off-label product use and disclose all relevant financial relationships. Faculty disclosure will be provided in the activity materials.
Commercial Support
This activity is supported by educational funding provided by Amgen; an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.; an educational grant from Sanofi US; an educational grant from Sanofi US and Regeneron; and an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc. and Lilly USA, LLC.